WHO: Obesity and overweight. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight 2024. Accessed 07/01/2025.
Okunogbe A, Nugent R, Spencer G, Powis J, Ralston J, Wilding J. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022;7(9). https://doi.org/10.1136/bmjgh-2022-009773.
Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025. https://doi.org/10.1016/S2213-8587(24)00316-4
World Health Organisation. European Regional Obesity Report 2022. Copenhagen: WHO Regional Office for Europe; 2022.
Chodick G, Simchoni M, Jensen BW, Derazne E, Pinhas-Hamiel O, Landau R, et al. Heritability of body mass index among familial generations. JAMA Netw Open. 2024;7(6):e2419029. https://doi.org/10.1001/jamanetworkopen.2024.19029.
Article PubMed PubMed Central Google Scholar
Gorczynska-Kosiorz S, Kosiorz M, Dziegielewska-Gesiak S. Exploring the interplay of genetics and nutrition in the rising epidemic of obesity and metabolic diseases. Nutrients. 2024;16(20). https://doi.org/10.3390/nu16203562.
Lee AJ, Cullerton K, Herron LM. Achieving food system transformation: iInsights from a retrospective review of nutrition policy (in)Action in high-income countries. Int J Health Policy Manag. 2021;10(12):766–83. https://doi.org/10.34172/ijhpm.2020.188.
Zizka O, Haluzik M, Jude EB. Pharmacological treatment of obesity in older adults. Drugs Aging. 2024;41(11):881–96. https://doi.org/10.1007/s40266-024-01150-9.
Article CAS PubMed PubMed Central Google Scholar
Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond). 2019;19(3):205–12. https://doi.org/10.7861/clinmedicine.19-3-205.
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205–16. https://doi.org/10.1056/NEJMoa2206038.
Article CAS PubMed Google Scholar
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22. https://doi.org/10.1056/NEJMoa1411892.
Article CAS PubMed Google Scholar
Walmsley R, Sumithran P. Current and emerging medications for the management of obesity in adults. Med J Aust. 2023;218(6):276–83. https://doi.org/10.5694/mja2.51871.
Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024;391(2):109–21. https://doi.org/10.1056/NEJMoa2403347.
Article CAS PubMed Google Scholar
Dobbie LJ, Coelho C, Mgaieth F, Chauhan K, Campbell S, Shuriye S, et al. Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real-world UK data: A clinical evaluation of a multi-ethnic population. Clin Obes. 2024;14(3):e12649. https://doi.org/10.1111/cob.12649.
Rose G. Sick individuals and sick populations. Int J Epidemiol. 1985;14(1):32–8. https://doi.org/10.1093/ije/14.1.32.
Article CAS PubMed Google Scholar
(NFS) NaFS. Report of the commission on ending childhood obesity. World Health Organization; 2016. p. 68.
Organisation WO: The roots of Obesity. https://www.worldobesity.org/what-we-do/our-policy-priorities/the-roots-of-obesity (2020). Accessed 13/01/25.
Vlad I, Oldridge-Turner K, Klepp KI, Rutter H, Mathisen JR, Helleve A, et al. The development of the NOURISHING and MOVING benchmarking tools to monitor and evaluate national governments’ nutrition and physical activity policies to address obesity in the European region. Obes Rev. 2023;24(Suppl 1):e13541. https://doi.org/10.1111/obr.13541.
Hawkes C, Jewell J, Allen K. A food policy package for healthy diets and the prevention of obesity and diet-related non-communicable diseases: the NOURISHING framework. Obes Rev. 2013;14(Suppl 2):159–68. https://doi.org/10.1111/obr.12098.
Oldridge-Turner K, Kokkorou M, Sing F, Klepp KI, Rutter H, Helleve A, et al. Promoting Physical Activity Policy: The Development of the MOVING Framework. J Phys Act Health. 2022;19(4):292–315. https://doi.org/10.1123/jpah.2021-0732.
Kanter R, Vanderlee L, Vandevijvere S. Front-of-package nutrition labelling policy: global progress and future directions. Public Health Nutr. 2018;21(8):1399–408. https://doi.org/10.1017/S1368980018000010.
Article PubMed PubMed Central Google Scholar
Lobstein T, Neveux M, Landon J. Costs, equity and acceptability of three policies to prevent obesity: A narrative review to support policy development. Obes Sci Pract. 2020;6(5):562–83. https://doi.org/10.1002/osp4.423.
Article PubMed PubMed Central Google Scholar
Sassi F, Cecchini M, Lauer J, Chisholm D. Improving lifestyles, tackling obesity: The health and economic impact of prevention strategies, OECD Health Working Papers, No. 48. Paris: OECD Publishing; 2009. https://doi.org/10.1787/220087432153.
Shangguan S, Afshin A, Shulkin M, Ma W, Marsden D, Smith J, et al. A Meta-Analysis of food labeling effects on consumer diet behaviors and industry practices. Am J Prev Med. 2019;56(2):300–14. https://doi.org/10.1016/j.amepre.2018.09.024.
Lan X, Sulaiman N. Public Policies on Obesity: A Literature Review of Global Challenges and Response Strategies. Cureus. 2024;16(6):e62758. https://doi.org/10.7759/cureus.62758.
Article PubMed PubMed Central Google Scholar
Bank W. Taxes on sugar-sweetened beverages: international evidence and experiences. World Bank; 2020.
Thow AM, Downs SM, Mayes C, Trevena H, Waqanivalu T, Cawley J. Fiscal policy to improve diets and prevent noncommunicable diseases: from recommendations to action. Bull World Health Organ. 2018;96(3):201–10. https://doi.org/10.2471/BLT.17.195982.
Article PubMed PubMed Central Google Scholar
OECD. The Heavy Burden of Obesity: The Economics of Prevention, OECD Health Policy Studies. OECD Publishing; 2019.
Zoh RS, Esteves BH, Yu X, Fairchild AJ, Vazquez AI, Chapple AG, et al. Design, analysis, and interpretation of treatment response heterogeneity in personalized nutrition and obesity treatment research. Obes Rev. 2023;24(12):e13635. https://doi.org/10.1111/obr.13635.
Article PubMed PubMed Central Google Scholar
Keramat SA, Alam K, Al-Hanawi MK, Gow J, Biddle SJH, Hashmi R. Trends in the prevalence of adult overweight and obesity in Australia, and its association with geographic remoteness. Sci Rep. 2021;11(1):11320. https://doi.org/10.1038/s41598-021-90750-1.
Article CAS PubMed PubMed Central Google Scholar
Wheaton N, Alston E, Versace VL, Field M, Wong Shee A, Jacobs J, et al. Diet-related disease prevention in a rural Australian setting: understanding barriers, enablers, and the role of rural health services in supporting changes in local rural food environments. Nutrients. 2023;15(23). https://doi.org/10.3390/nu15234979.
Liburd LC, Hall JE, Mpofu JJ, Williams SM, Bouye K, Penman-Aguilar A. Addressing health equity in public health practice: frameworks, promising strategies, and measurement considerations. Annu Rev Public Health. 2020;41:417–32. https://doi.org/10.1146/annurev-publhealth-040119-094119.
Needham C, Sacks G, Orellana L, Robinson E, Allender S, Strugnell C. A systematic review of the Australian food retail environment: Characteristics, variation by geographic area, socioeconomic position and associations with diet and obesity. Obes Rev. 2020;21(2):e12941. https://doi.org/10.1111/obr.12941.
Ziso D, Chun OK, Puglisi MJ. Increasing access to healthy foods through improving food environment: a review of mixed methods intervention studies with residents of low-income communities. Nutrients. 2022;14(11). https://doi.org/10.3390/nu14112278.
Wharton S, Lau DCW, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ. 2020;192(31):E875–91. https://doi.org/10.1503/cmaj.191707.
Article PubMed PubMed Central Google Scholar
Ahern AL, Breeze P, Fusco F, Sharp SJ, Islam N, Wheeler GM, et al. Effectiveness and cost-effectiveness of referral to a commercial open group behavioural weight management programme in adults with overweight and obesity: 5-year follow-up of the WRAP randomised controlled trial. Lancet Public Health. 2022;7(10):e866–75. https://doi.org/10.1016/S2468-2667(22)00226-2.
Lean ME, Leslie WS, Barnes AC, Brosnahan N, Thom G, McCombie L, et al. 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study. Lancet Diabetes Endocrinol. 2024;12(4):233–46. https://doi.org/10.1016/S2213-8587(23)00385-6.
Brown J CC, Johnson Stoklossa C: Canadian obesity clinical practice guidelines: Medical Nutrition Therapy in obesity management. https://obesitycanada.ca/guidelines/nutrition/ (2022). Accessed 07/01/2025.
Raynor HA, Morgan-Bathke M, Baxter SD, Halliday T, Lynch A, Malik N, et al. Position of the Academy of Nutrition and Dietetics: Medical Nutrition Therapy Behavioral Interventions provided by dietitians for adults with overweight or obesity, 2024. J Acad Nutr Diet. 2024;124(3):408–15. https://doi.org/10.1016/j.jand.2023.11.013.
Comments (0)